Which Diabetes Patients Will Benefit the Most from Once-Weekly Basal Insulin Analogs? A Review with a Special Focus on Type 1 Diabetes Patients.
Saved in:
| Title: | Which Diabetes Patients Will Benefit the Most from Once-Weekly Basal Insulin Analogs? A Review with a Special Focus on Type 1 Diabetes Patients. |
|---|---|
| Authors: | Kosmeri, Chrysoula1 (AUTHOR) chrisa.kosmeri@gmail.com, Baltogianni, Maria2 (AUTHOR) mbalt@doctors.org.uk, Giapros, Vasileios2 (AUTHOR) faybal18@yahoo.com, Siomou, Ekaterini1 (AUTHOR) eksiomou@uoi.gr, Tsinopoulou, Vasiliki-Regina3 (AUTHOR) vasotsino@gmail.com, Balomenou, Foteini2 (AUTHOR), Serbis, Anastasios1 (AUTHOR) tasos_serbis@yahoo.com |
| Source: | Endocrines. Jun2024, Vol. 5 Issue 2, p214-224. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2673396X |
|---|---|
| DOI: | 10.3390/endocrines5020015 |